Posted by Clinical Lab Products | Jul 9, 2010 | Cancer, Miscellaneous |
Researchers at Whitehead Institute and Childrens Hospital Boston have identified a protein, called Musashi 2, that is predictive of prognosis in acute myeloid leukemia (AML) and chronic myeloid leukemia (CML) patients.
Read MorePosted by Clinical Lab Products | Jun 9, 2010 | Miscellaneous |
Biomerica Inc announced that it has purchased a patented technology and the manufacturing rights for a new Thiopurine methyltransferase (TPMT) test to detect patients who are at risk of developing severe side effects.
Read MorePosted by Clinical Lab Products | Apr 22, 2010 | Cancer, Miscellaneous |
QIAGEN has announced the appointment of two high level members, Dr Pia Garguilo and Richard Watts, to the recently formed Pharma Business Development team.
Read MorePosted by Clinical Lab Products | Apr 16, 2010 | Cancer, Miscellaneous |
PerkinElmer Inc has announced that it has entered into a definitive agreement to acquire Signature Genomic Laboratories LLC, a diagnostic genetic testing company based in Spokane, Wash.
Read MorePosted by Clinical Lab Products | Apr 13, 2010 | Cancer, Miscellaneous |
Researchers from the Childrens Cancer Hospital at The University of Texas M. D. Anderson Cancer Center may have found a way to more accurately predict treatment outcomes in young leukemia patients using information from a common and simple complete blood count test, also known as a CBC.
Read More